Tumescent Solution Color Indicators for IV Safety
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Tumescent solutions, such as those containing epinephrine and lidocaine, pose a risk of inadvertent intravenous infusion due to their similarity in appearance to saline solutions, leading to potential toxicity, as there is no effective means to easily and rapidly identify IV bags containing these drugs, especially in busy clinical settings where labels may be misread or misunderstood.
Innovation Solution
Incorporating non-toxic color-indicators like Vitamin B12 or Vitamin B2 into the tumescent solutions, which impart a distinctive pink or yellow color, respectively, to visually differentiate them from saline solutions, thereby serving as a warning against intravenous infusion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If tumescent solutions are formulated without color indicators, then the solution remains clear and visually similar to saline, but this creates a high risk of inadvertent intravenous infusion and potential toxicity
Solution Approach 1:
The patent applies color changes by incorporating Vitamin B12 (pink color) or Vitamin B2 (yellow color) into the tumescent solution. These vitamins serve as visual indicators that immediately distinguish the tumescent solution from clear saline, preventing inadvertent intravenous infusion. The color change principle directly addresses the safety issue while maintaining solution clarity and visual detectability.
Solution Approach 2:
The patent uses vitamins B12 or B2 as intermediary substances that serve dual purposes: they act as visual color indicators to prevent misidentification, and simultaneously function as therapeutic agents with potential analgesic and wound-healing properties. This intermediary approach resolves the contradiction by adding a substance that provides both safety differentiation and therapeutic benefit.
2Difficulty of detecting and measuring
If color indicators are added to tumescent solutions, then visual differentiation from saline is achieved, but the solution composition becomes more complex
Solution Approach 1:
The patent implements color changes by adding Vitamin B12 (pink) or Vitamin B2 (yellow) to create visually distinct tumescent solutions. This directly improves visual identification difficulty by providing immediate color-based differentiation from clear saline, while the complexity increase is minimal since these are standard vitamin supplements.
Solution Approach 2:
The patent applies universality by selecting vitamins that serve multiple functions: they provide visual color indication for safety, and simultaneously offer therapeutic benefits including potential pain relief and wound healing promotion. This multi-functionality reduces the need for separate indicator substances, thereby limiting the increase in solution complexity.
3Illumination intensity
If vitamins B12 or B2 are used as color indicators, then distinctive colors are imparted to the solution, but this requires selection from multiple vitamin options
Solution Approach 1:
The patent applies color changes by specifically selecting Vitamin B12 for pink color or Vitamin B2 for yellow color in the tumescent solution. This provides distinctive visible colors that enhance visual identification and prevent misadministration, while the selection process is guided by the desired color outcome and therapeutic properties.
Solution Approach 2:
The patent applies local quality by allowing different vitamin selections based on specific clinical needs and desired color characteristics. Clinicians can choose between B12 (pink) or B2 (yellow) depending on the specific procedure requirements, patient preferences, or institutional protocols, providing localized adaptability within the overall solution formulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of Vitamin B12 or B2 as color-indicators in tumescent solutions effectively prevents inadvertent IV infusion by providing a visible and non-verbal warning, enhancing patient safety by clearly distinguishing these solutions from standard saline solutions, thus reducing the risk of toxicity.
Implementation Method 1
a B vitamin that may impart a visible color to the solution
Data Source
AI summary
A tumescent solution including: a vasoconstrictor; a B vitamin and a pharmaceutically acceptable carrier. In some examples, the tumescent solution further includes a drug or therapeutic agent dissolved in the tumescent solution. Some examples relate to a method of subcutaneous delivery of a drug or therapeutic agent to a subject including subcutaneously administering to said subject a tumescent solution as disclosed herein. In some examples, infiltration of the tumescent solution achieves both prolonged local drug or therapeutic agent concentration within a tumescent subcutaneous tissue as well as a prolonged slow constant systemic absorption of drugs from the tumescent tissue into a systemic circulation. In some examples, the tumescent solution reduces neuropathic pain or the risk of developing neuropathic pain, treats a localized condition or reduces persistent postsurgical pain (PPP) in a subject.